Latest Breaking News On - தொழில்நுட்பங்கள் துறை - Page 1 : comparemela.com

HJF Receives Patent for Potential Treatment for Nerve Agent Exposure News provided by Share this article Share this article BETHESDA, Md., May 11, 2021 /PRNewswire/  The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) received notice of allowance for a patent from the United States Patent Office (USPO) for a medical countermeasure to organophosphate (OP) nerve agent exposure. Among OP nerve agents is the deadly chemical weapon, Sarin. Led by Maria F. Braga, DDS, PhD, a professor of Anatomy, Physiology and Genetics, and Psychiatry in the in the School of Medicine at the Uniformed Services University of the Health Sciences (USU), researchers identified a neuroprotective combination therapy that is effective against OP exposure. The therapy was shown to be effective even with delayed use following nerve agent exposure. This innovation was patented by the USU/HJF Joint Office of Technology Transfer.

Eli lillyHenrym jackson foundationTechnologies departmentNational institute of healthDepartment of defenseDefense threat reduction agency chemicalDefense threat reduction agencyBiological technologies departmentNational instituteMilitary medicineஎலி லில்லிதொழில்நுட்பங்கள் துறைதேசிய நிறுவனம் ஆஃப் ஆரோக்கியம்துறை ஆஃப் பாதுகாப்புஉயிரியல் தொழில்நுட்பங்கள் துறைதேசிய நிறுவனம்